WO2007083672A1 - 繊維処理剤、繊維処理方法、この繊維処理剤により処理された繊維および布帛 - Google Patents

繊維処理剤、繊維処理方法、この繊維処理剤により処理された繊維および布帛 Download PDF

Info

Publication number
WO2007083672A1
WO2007083672A1 PCT/JP2007/050613 JP2007050613W WO2007083672A1 WO 2007083672 A1 WO2007083672 A1 WO 2007083672A1 JP 2007050613 W JP2007050613 W JP 2007050613W WO 2007083672 A1 WO2007083672 A1 WO 2007083672A1
Authority
WO
WIPO (PCT)
Prior art keywords
fiber
dna
treatment agent
fiber treatment
rna
Prior art date
Application number
PCT/JP2007/050613
Other languages
English (en)
French (fr)
Japanese (ja)
Inventor
Nobuo Kusamoto
Masashi Sakamoto
Shigeru Oyama
Hajime Ito
Kazutoshi Amano
Masaji Matsunaga
Fumihito Yoshida
Original Assignee
Idemitsu Technofine Co., Ltd.
Nissei Bio Company, Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Idemitsu Technofine Co., Ltd., Nissei Bio Company, Limited filed Critical Idemitsu Technofine Co., Ltd.
Priority to JP2007554927A priority Critical patent/JPWO2007083672A1/ja
Publication of WO2007083672A1 publication Critical patent/WO2007083672A1/ja

Links

Classifications

    • DTEXTILES; PAPER
    • D06TREATMENT OF TEXTILES OR THE LIKE; LAUNDERING; FLEXIBLE MATERIALS NOT OTHERWISE PROVIDED FOR
    • D06MTREATMENT, NOT PROVIDED FOR ELSEWHERE IN CLASS D06, OF FIBRES, THREADS, YARNS, FABRICS, FEATHERS OR FIBROUS GOODS MADE FROM SUCH MATERIALS
    • D06M15/00Treating fibres, threads, yarns, fabrics, or fibrous goods made from such materials, with macromolecular compounds; Such treatment combined with mechanical treatment
    • D06M15/01Treating fibres, threads, yarns, fabrics, or fibrous goods made from such materials, with macromolecular compounds; Such treatment combined with mechanical treatment with natural macromolecular compounds or derivatives thereof
    • D06M15/03Polysaccharides or derivatives thereof
    • DTEXTILES; PAPER
    • D06TREATMENT OF TEXTILES OR THE LIKE; LAUNDERING; FLEXIBLE MATERIALS NOT OTHERWISE PROVIDED FOR
    • D06MTREATMENT, NOT PROVIDED FOR ELSEWHERE IN CLASS D06, OF FIBRES, THREADS, YARNS, FABRICS, FEATHERS OR FIBROUS GOODS MADE FROM SUCH MATERIALS
    • D06M10/00Physical treatment of fibres, threads, yarns, fabrics, or fibrous goods made from such materials, e.g. ultrasonic, corona discharge, irradiation, electric currents, or magnetic fields; Physical treatment combined with treatment with chemical compounds or elements
    • DTEXTILES; PAPER
    • D06TREATMENT OF TEXTILES OR THE LIKE; LAUNDERING; FLEXIBLE MATERIALS NOT OTHERWISE PROVIDED FOR
    • D06MTREATMENT, NOT PROVIDED FOR ELSEWHERE IN CLASS D06, OF FIBRES, THREADS, YARNS, FABRICS, FEATHERS OR FIBROUS GOODS MADE FROM SUCH MATERIALS
    • D06M15/00Treating fibres, threads, yarns, fabrics, or fibrous goods made from such materials, with macromolecular compounds; Such treatment combined with mechanical treatment
    • D06M15/19Treating fibres, threads, yarns, fabrics, or fibrous goods made from such materials, with macromolecular compounds; Such treatment combined with mechanical treatment with synthetic macromolecular compounds
    • D06M15/21Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds
    • D06M15/263Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds of unsaturated carboxylic acids; Salts or esters thereof
    • DTEXTILES; PAPER
    • D06TREATMENT OF TEXTILES OR THE LIKE; LAUNDERING; FLEXIBLE MATERIALS NOT OTHERWISE PROVIDED FOR
    • D06MTREATMENT, NOT PROVIDED FOR ELSEWHERE IN CLASS D06, OF FIBRES, THREADS, YARNS, FABRICS, FEATHERS OR FIBROUS GOODS MADE FROM SUCH MATERIALS
    • D06M15/00Treating fibres, threads, yarns, fabrics, or fibrous goods made from such materials, with macromolecular compounds; Such treatment combined with mechanical treatment
    • D06M15/19Treating fibres, threads, yarns, fabrics, or fibrous goods made from such materials, with macromolecular compounds; Such treatment combined with mechanical treatment with synthetic macromolecular compounds
    • D06M15/21Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds
    • D06M15/285Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds of unsaturated carboxylic acid amides or imides
    • DTEXTILES; PAPER
    • D06TREATMENT OF TEXTILES OR THE LIKE; LAUNDERING; FLEXIBLE MATERIALS NOT OTHERWISE PROVIDED FOR
    • D06MTREATMENT, NOT PROVIDED FOR ELSEWHERE IN CLASS D06, OF FIBRES, THREADS, YARNS, FABRICS, FEATHERS OR FIBROUS GOODS MADE FROM SUCH MATERIALS
    • D06M15/00Treating fibres, threads, yarns, fabrics, or fibrous goods made from such materials, with macromolecular compounds; Such treatment combined with mechanical treatment
    • D06M15/19Treating fibres, threads, yarns, fabrics, or fibrous goods made from such materials, with macromolecular compounds; Such treatment combined with mechanical treatment with synthetic macromolecular compounds
    • D06M15/21Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds
    • D06M15/356Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds of other unsaturated compounds containing nitrogen, sulfur, silicon or phosphorus atoms
    • DTEXTILES; PAPER
    • D06TREATMENT OF TEXTILES OR THE LIKE; LAUNDERING; FLEXIBLE MATERIALS NOT OTHERWISE PROVIDED FOR
    • D06MTREATMENT, NOT PROVIDED FOR ELSEWHERE IN CLASS D06, OF FIBRES, THREADS, YARNS, FABRICS, FEATHERS OR FIBROUS GOODS MADE FROM SUCH MATERIALS
    • D06M15/00Treating fibres, threads, yarns, fabrics, or fibrous goods made from such materials, with macromolecular compounds; Such treatment combined with mechanical treatment
    • D06M15/19Treating fibres, threads, yarns, fabrics, or fibrous goods made from such materials, with macromolecular compounds; Such treatment combined with mechanical treatment with synthetic macromolecular compounds
    • D06M15/37Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
    • D06M15/564Polyureas, polyurethanes or other polymers having ureide or urethane links; Precondensation products forming them
    • DTEXTILES; PAPER
    • D06TREATMENT OF TEXTILES OR THE LIKE; LAUNDERING; FLEXIBLE MATERIALS NOT OTHERWISE PROVIDED FOR
    • D06MTREATMENT, NOT PROVIDED FOR ELSEWHERE IN CLASS D06, OF FIBRES, THREADS, YARNS, FABRICS, FEATHERS OR FIBROUS GOODS MADE FROM SUCH MATERIALS
    • D06M15/00Treating fibres, threads, yarns, fabrics, or fibrous goods made from such materials, with macromolecular compounds; Such treatment combined with mechanical treatment
    • D06M15/19Treating fibres, threads, yarns, fabrics, or fibrous goods made from such materials, with macromolecular compounds; Such treatment combined with mechanical treatment with synthetic macromolecular compounds
    • D06M15/37Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
    • D06M15/643Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds containing silicon in the main chain
    • DTEXTILES; PAPER
    • D06TREATMENT OF TEXTILES OR THE LIKE; LAUNDERING; FLEXIBLE MATERIALS NOT OTHERWISE PROVIDED FOR
    • D06MTREATMENT, NOT PROVIDED FOR ELSEWHERE IN CLASS D06, OF FIBRES, THREADS, YARNS, FABRICS, FEATHERS OR FIBROUS GOODS MADE FROM SUCH MATERIALS
    • D06M23/00Treatment of fibres, threads, yarns, fabrics or fibrous goods made from such materials, characterised by the process
    • D06M23/12Processes in which the treating agent is incorporated in microcapsules

Definitions

  • Fiber treatment agent Fiber treatment agent, fiber treatment method, fiber and fabric treated with this fiber treatment agent
  • the present invention relates to a fiber treatment agent, a fiber treatment method, and fibers and fabrics treated with the fiber treatment agent.
  • These fiber products have different characteristics required for the fibers used as the material due to differences in various applications. Examples of these required properties include moisture retention, water absorption, hygroscopicity, and antistatic properties.
  • fibers are used.
  • the fiber material suitable for such use include synthetic fibers such as nylon, polyester, acrylic, and polyurethane, and natural fibers such as cotton, hemp, and wool, and composite fibers thereof.
  • these fiber materials are treated with a specific fiber treating agent to improve the above characteristics, or to give special characteristics in addition to the above characteristics. It has been.
  • a fiber treatment material containing a functional protein obtained by treatment with a crosslinking agent and a solvent-based resin or an aqueous resin. Etc. are known.
  • Patent Document 1 Japanese Patent Application No. 9-537916 (International Publication WO97Z40227)
  • the object of the present invention is to provide moisture retention, water absorption, hygroscopicity, anti-static properties with good durability! /, In addition to conventional techniques, wound healing, pressure ulcer prevention and recovery, prevention of rough skin and
  • An object of the present invention is to provide a fiber treatment agent capable of continuously expressing UV cut, a fiber treatment method, a fiber and a fabric treated with the fiber treatment agent.
  • the fiber treatment agent of the present invention is a fiber treatment agent used for treating a fiber surface, and is DNA, DNA metal salt (eg, K, Ca, Na, Mg, etc.) or RNA, DNA or RNA Enzymatic degradation products or hydrolysis products, deoxyoligonucleotides, deoxymononucleotides, oligonucleotides, mononucleotides (hereinafter referred to as DNA and Z or RNA, etc.) separated from the degradation products Or at least one mixture selected from the decomposition products or the aforementioned compounds.
  • DNA metal salt eg, K, Ca, Na, Mg, etc.
  • RNA DNA or RNA Enzymatic degradation products or hydrolysis products
  • deoxyoligonucleotides deoxymononucleotides
  • oligonucleotides oligonucleotides
  • mononucleotides hereinafter referred to as DNA and Z or RNA, etc.
  • any solvent can be used as long as it can be used for the fiber treatment agent, but water is most preferable from the viewpoint of safety.
  • the fiber can be provided with functions such as moisture retention, water absorption, hygroscopicity, antistatic property, and UV cut effect. wear.
  • the fiber can be absorbed through the skin, improving peripheral blood flow, and producing cellular TP, so that wound healing, pressure ulcer prevention and Immediate expression of recovery, prevention of rough skin, and reduction of the effects of ultraviolet rays.
  • the above-mentioned DNA and Z or RNA of the polymer is a DNA degrading enzyme present in the skin
  • Nucleoprotein consisting of protamine, DNA and Z or RNA
  • DNA can be obtained, for example, by extracting and purifying fish's baby power. Examples of the fish are salmon, salmon, salmon, and salmon, and salmon is particularly preferable. DNA is described in more detail below.
  • the DNA that is the raw material for production of the present invention may have various forms, for example, double-stranded, single-stranded or circular DNA.
  • the source of DNA is various organisms such as animals, plants, and microorganisms. Fish, particularly sharks, sharks, sharks, and shark testes (white eggs), which are wastes from marine processing, contain a lot of DNA, but they have not been used effectively as resources and have been discarded. Therefore, it is desirable to use DNA derived from these testes from the viewpoint of waste recycling.
  • DNA obtained from mammals and birds for example, thymus frogs such as rabbits, pigs, and chickens can be used.
  • synthetic DNA can also be used.
  • RNA can be obtained, for example, by extracting and purifying from yeast.
  • a part or all of the four bases constituting DNA and Z or RNA may react with other functional groups without any problem. By doing so, the compatibility with other components and fibers of the fiber treatment agent described later is improved, or the base is modified with a part of the hydrophobic group, so that a more durable fiber treatment agent can be obtained. Obtainable.
  • DNA is usually a polymer, so that it can be easily dissolved in water, which is the most preferred solvent for fiber treatment agents.
  • the macromolecular DNA and Z or RNA used in the present invention have functions such as moisture retention, water absorption, hygroscopicity, and antistaticity, and gradually decompose to deoxyoligonucleotides, deoxymononucleotides, oligonucleotides, Both of which become mononucleotide and perform functions such as wound healing
  • another fiber treatment agent can be obtained by using other components in addition to the above-described DNA and Z or RNA.
  • Such another fiber treating agent of the present invention will be described below.
  • Another fiber treatment agent of the present invention is characterized by containing the above-described DNA, Z, or RNA, and a reactive organic compound having a reactive group or an organic compound having adhesiveness. .
  • the fiber treatment agent component mainly DNA, Z, RNA, etc.
  • the reactive organic compound includes (Component 1) a hydrophilic compound having a polymerizable bur group in the molecule, (Component 2) a hydroxyl group, a carboxyl group, an amino group, a sulfonic acid group, As a monomer containing a phosphate group, (Component 3) a hydrophilic compound having an epoxy group, and (Component 4) a compound having an aziridine group, at least one of these components 1 to 4 can be used. Or prefer to contain one or more!
  • component 1 examples include polyethylene glycol diatalylate, polyethylene glycol dimetatalylate, bisphenol A polyethylene glycol diathalate, bisphenol A polyethylene glycol dimetatalylate, bisphenol S polyethylene glycol dimethyl ester. Such as tartrate.
  • component 2 examples include acrylic acid, methacrylic acid, maleic acid, itaconic acid, acrylic amide, methacrylamide, bululsulfonic acid, hydroxypropyl methacrylate and the like.
  • component 3 examples include polyethylene glycol diglycidyl ether.
  • component 4 examples include compounds having the following chemical formula (1).
  • a fiber treatment agent is prepared by preparing the above-described DNA and Z or RNA in an appropriate solvent, for example, an aqueous solution, and a reactive organic compound.
  • an appropriate solvent for example, an aqueous solution
  • a reactive organic compound for example, an aqueous solution
  • proteins such as fib mouth-in, sericin, eggshell membranes, and polysaccharides such as chitosan and cellulose may be blended. By combining these, the effect of improving hygroscopicity can be obtained.
  • 0.1 to 10% by mass of the DNA and Z or RNA or the like is included with respect to the total amount of the fiber treatment agent, and the reactive organic compound strength is about 20 to 20% by mass. It is preferably included. More preferably, the DNA and Z or RNA are contained in an amount of 0.2 to 5% by mass, and the reactive organic compound is contained in an amount of 2 to 10% by mass.
  • the DNA and Z or RNA or the like is less than 0.1% by mass and the reactive organic compound is less than 1% by mass, effects such as moisture retention become insufficient. Moreover, when DNA and Z or RNA etc. exceed 10 mass% and the said reactive organic compound exceeds 20 mass%, the fiber processed may become hard.
  • Another fiber treatment agent of the present invention is characterized by containing the above-described DNA and Z or RNA and an organic compound having adhesiveness.
  • the organic compound having adhesiveness since the organic compound having adhesiveness is contained, it is possible to prevent the fiber treatment agent component (mainly DNA) from being peeled off due to washing or friction.
  • the organic compound having adhesiveness has a function as a so-called adhesive resin, and fixes an active ingredient (mainly DNA and Z or RNA) of the fiber treatment agent to the fiber. If there is, there is no particular limitation.
  • component 1 to component 4 component 5 (compound having isocyanate and Z or its precursor), acrylic resin, polyurethane resin, silicon resin, silicon-containing acrylic resin. It is preferably an adhesive resin that also has at least one force selected.
  • Specific examples of the compound having an isocyanate group among the components 5 include hexamethylene diisocyanate and 1, 3, 5 triisocyanate 1-to-n-pentane represented by the chemical formulas (i) and (ii). be able to.
  • the compound having a precursor of an isocyanate group include a precursor of hexamethylene diisocyanate and a precursor of 1,3,5 triisocyanate n-pentane.
  • the body can be mentioned.
  • the precursors of hexamethylene diisocyanate include 1,6 di (methylcarbamoyl) -n-hexane and 1,6 di (phenolcarbamoyl) represented by chemical formulas (iii) and (iv). — N-hexane.
  • a compound represented by the chemical formula (V) can be mentioned as a precursor of 1,3,5-triisocyanate-n-pentane.
  • the terminal amino group strength of ether type, ester type, or carbonate type polyurethane is chemically modified with methoxycarbonyl group, ethoxycarbonyl group, phenoxy strength group, and the like.
  • Polymers or oligomers having a carbamate group of a different structure for example, Elastolon (registered trademark) or Superflex (registered trademark) manufactured by Daiichi Kogyo Seiyaku Co., Ltd.), etc. can also be used.
  • weak alkali salts such as sodium hydrogen carbonate and Z or organotin are used for the purpose of enhancing the ability to remove the modification group during heating in fiber processing.
  • an organic lead-based catalyst may be used in combination.
  • the organic compound having the sticking property is a lipophilic compound such as wax and silicon, and Z or ether, acrylic, urethane, amide, ester.
  • a polymer compound containing a group such as
  • the organic compound having adhesiveness is not reactive, but has an appropriate lipophilicity or hydrophilicity per se, and is an organic compound that adheres to the fiber surface, and is a softener for fibers and fabrics.
  • examples of the lipophilic compound include neutral oils and fats, mineral oils and animal meals in addition to wax and silicon
  • examples of polymer compounds include acrylic resin, Examples thereof include polyurethane resins and silicon-containing acrylic resins.
  • the above-described DNA and Z or RNA are bonded to the fiber surface by such lipophilic compound and Z or polymer compound, and the DNA and Z are immersed in the fiber.
  • elution of RNA or the like out of the fiber can be prevented.
  • the reactive organic compound described above it is possible to prevent DNA and / or RNA from being removed even if fibers subjected to fiber treatment are used for a long period of time.
  • the above-mentioned reactive organic compound! / ⁇ should be fixed by mechanical means such as microcapsules in addition to fixing of DNA and / or RNA by an organic compound having stickiness.
  • the above-described DNA, Z, or RNA may be included in the microcapsule in a solid state and dissolved in Z or a solvent in order to further improve washing durability and the like.
  • DNA, Z, RNA, etc. which are particularly soluble in water, can be prevented from eluting out of the fiber, so that the washing durability is excellent.
  • DNA, Z, RNA, etc. average particle size: 10 ⁇ m or less
  • water-insoluble (meth) acrylic monomers eg, ethyl acrylate, butyl acrylate, methyl methacrylate, acrylic acid, etc.
  • a surfactant or the like may be added.
  • Heat after adding polymerization initiator, or UV (Meth) acrylic monomer is polymerized by irradiation with water to produce water-insoluble capsules.
  • a water-insoluble thermosetting polyurethane resin may be used in place of the (meth) acrylic monomer.
  • aqueous solution such as DNA and Z or RNA
  • water-soluble (meth) acrylic monomer eg, sodium acrylate, 2-hydroxyethyl (meth) acrylate, acrylic acid, etc.
  • polymerization start Add the agent, impregnate this aqueous solution into fine silica gel or zeolite fine particles, disperse it in water or water Z alcohol mixture liquid, and then heat or irradiate ultraviolet rays, so Manufacturing.
  • Warm water (50-60 ° C) containing gelatin and DNA and / or RNA (powder or aqueous solution) is dispersed in a hydrophobic organic solvent at the same temperature and then cooled, and then isopropanol is added dropwise to the solvent system. It solidifies and hardens by soaking in aldehyde after filtration.
  • the fibers of the present invention can be obtained by applying each of the fiber treatment agents of the present invention described above to an existing fiber material.
  • the fiber of the present invention is characterized by being treated with the above-described fiber treating agent of the present invention.
  • the fiber include synthetic fibers such as nylon, polyester, acrylic, and polyurethane, cotton, hemp, and wool. Natural fibers such as these, and these composite fibers are also included.
  • the treatment method for the fiber treatment agent may be any treatment method.
  • a dipping method, a padding method, or the like can be used.
  • the dipping method include a room temperature standing method and a heating and stirring method.
  • Examples of the padding method include a node dry method and a pad steam method, but any method may be used in the case of a reactive organic compound.
  • the fiber coated or impregnated with the fiber treatment agent of the present invention may be irradiated with an electron beam or radiation.
  • a reactive organic compound or an organic compound having adhesiveness can be cross-linked to form a stronger film on the fiber, and further, the fiber material can be cross-linked using a radical generated on the fiber surface as a starting point.
  • DNA, Z, or RNA can be directly bonded to the material. According to these, by being treated with the above-mentioned fiber treatment agent, it has good durability, moisture retention, water absorption, moisture absorption, antistatic, wound healing, pressure ulcer prevention and recovery, rough skin prevention, UV cut It can be set as the fiber which expresses an effect continuously.
  • the fabric of the present invention comprises 20% by weight or more of the above-described fiber of the present invention, and has a woven fabric, a knitted fabric, or a non-woven fabric.
  • FIG. 1 is a graph showing experimental results according to Example 1 of the present invention.
  • ⁇ ⁇ lOOOOg was taken, and blood was removed and washed with water. After draining, 300 ml of water was removed, ground and stirred to obtain a suspension.
  • this suspension was filtered to remove solids such as white skin, and then spray-dried with a spray dryer to obtain a powdery substance.
  • This powdery substance was washed with ethanol to remove ethanol-soluble substances and moisture, and dried under reduced pressure to obtain 180 g of a white child extract as a powder.
  • the white extract obtained by force is a pale yellow powder, and its chemical and physical properties are shown below.
  • Nucleic acid content 25-50%
  • nuclease for example, enzyme preparation nuclease “Amano” (manufactured by Amano Pharmaceutical Co., Ltd.)] approved as a food additive.
  • the produced mononucleotides and oligonucleotides were analyzed with an electrophoresis apparatus to determine the optimum conditions. Specifically, powdered DNA-Na salt is used as raw material in warm water adjusted to around 65 ° C. After stirring, the mixture is further heated to 70 ° C to cover 0.25% of nuclease with respect to the raw material. The reaction was performed for 3 hours. Next, the nuclease was inactivated by heating at 85 ° C. for 10 minutes, followed by centrifugation, and the supernatant was applied with a spray-drying method to obtain a dried oligonucleotide powder.
  • Powdered DNA-Na salt derived from white coconut is added as raw material to warm water adjusted to around 65 ° C. After stirring, the mixture is further heated to 70 ° C. 0.05%) was added and reacted for 3 hours. Next, the nuclease was inactivated by heating at 85 ° C. for 10 minutes, and then analyzed by HPLC (high performance liquid chromatography). The result is shown in Fig. 1. As shown in FIG. 1, the peak 26 and later indicated by the arrow P is the absorption of the oligonucleotide, and in Example 1, 31% was the fraction of the oligonucleotide.
  • Elastolone (registered trademark) manufactured by Daiichi Kogyo Seiyaku Co., Ltd. as an aqueous solution of DNA and oligonucleotide (5 wt%) extracted and purified from the silkworm obtained in (1) above, and a modified isocyanate-based reactive modifier.
  • F-29 and the catalysts were mixed in the following mixing ratio.
  • OkgZcm 2 mangle (a device that inserts the target cloth between two rolls, one of which is a metal roll and the other is a rubber roll, and squeezes out the water). 124%), dried for 5 minutes at 100 ° C with a commercial hot air dryer, and then heated at 170 ° C for 2 minutes.
  • the processed fabric was washed once by a method based on “JIS L0217 103 method” and dried at 100 ° C. for 5 minutes by a hot air dryer to obtain a fiber fabric (Example 1).
  • the fiber fabrics obtained in the above examples and comparative examples were washed 10 times by a method based on “JIS L0217 103 method” and then dried at 100 ° C. for 5 minutes by a hot air dryer.
  • Example 1 and Comparative Example 1 were each made into a fiber fabric after washing 10 times, respectively, as Example 2 and Comparative Example 2, respectively, and the following tests were conducted for a total of four types.
  • Table 1 shows the results of evaluations 1) to 3). [0053] [Table 1]
  • the softness and elasticity (recovery rate) of the skin were evaluated by measuring the skin height after suction using a cute meter (MPA580: manufactured by Integral Co., Ltd.).
  • the difference in skin height before and during suction is the tensile height (A), which is an indicator of skin flexibility.
  • A tensile height
  • BZA 1 when fully recovered.
  • test fabric was brought into contact with the human forearm by the following procedure, the skin softness and elasticity (recovery rate) of each part were evaluated.
  • test fabric (approx. lcm x 1cm) to the subject's test site and continuously contact the skin for approximately 8 hours.
  • test fabrics of Examples 1 and 2 and Comparative Examples 1 and 2 were fixed to the human upper arm, and after 1 hour, the blood flow was measured with a laser Doppler meter (CDS2000 manufactured by OSAS Co., Ltd.). did.
  • the test results were determined according to the following criteria.
  • the evaluation of the blood flow measurement test was +++ [the blood flow was extremely increased compared to before the test fabric was fixed (high effect)], whereas the evaluation of the blood flow measurement test of the comparative preparation was evaluated. There is a significant difference in the blood flow [the blood flow increased slightly tl (slightly effective) compared to before fixation of the test fabric], and it is clear that human skin force penetrates and blood flow is remarkably increased.
  • a fiber treatment agent was prepared by blending DNA-Na extracted from the coconut shell obtained in Example 1 and a reactive organic compound.
  • the concentration of each component of the fiber treatment agent is as follows.
  • Reactive organic compound (Chemical formula B) : 0.5%
  • the fiber treatment agent of the previous item After impregnating the fiber treatment agent of the previous item into a 20cm square size cotton knit (weight per unit area: 184 g / m 2 ), the fiber treatment agent was squeezed with a 0.4 Mpa mangle (drawing rate 100%). Thereafter, it was pre-dried at 50 ° C. for 20 minutes with a hot air dryer, and then heated at 110 ° C. for 30 minutes. The processed fabric was washed once by a method according to “JIS L0217 103 method” and then dried to obtain a fiber fabric.
  • a cotton knit was treated in the same manner as in Example 3 using the fiber treatment agent prepared in the previous section.
  • the drawing rate was 100%.
  • a fiber treating agent was prepared in the same manner as in Example 3 (1) except that the reactive organic compound (Chemical Formula B) was not used and water was changed to 85.0%.
  • a fiber treating agent was prepared in the same manner as in Example 3 (1) except that the reactive organic compounds (Chemical Formulas A and B) were not used and water was changed to 90.0%.
  • Cotton knit was treated in the same manner as in Example 3 (2), using the fiber treatment agent prepared in the previous section.
  • the drawing rate was 95%.
  • the amount of DNA-Na on the fiber fabrics obtained in Examples 1, 3, 4, 5 and Comparative Example 1 was measured. At this time, the amount of DNA-Na on the fiber fabric was quantified by the following method.
  • a fiber treatment agent, a fiber treatment method, and fibers and fabrics treated with the fiber treatment agent can be provided.
  • the present invention can be used for fibers such as blouse, dress shirts, pants, skirts, linings, and skin materials for seats of seats of furniture vehicles.

Landscapes

  • Engineering & Computer Science (AREA)
  • Textile Engineering (AREA)
  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PCT/JP2007/050613 2006-01-20 2007-01-17 繊維処理剤、繊維処理方法、この繊維処理剤により処理された繊維および布帛 WO2007083672A1 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2007554927A JPWO2007083672A1 (ja) 2006-01-20 2007-01-17 繊維処理剤、繊維処理方法、この繊維処理剤により処理された繊維および布帛

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2006-013246 2006-01-20
JP2006013246 2006-01-20

Publications (1)

Publication Number Publication Date
WO2007083672A1 true WO2007083672A1 (ja) 2007-07-26

Family

ID=38287623

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2007/050613 WO2007083672A1 (ja) 2006-01-20 2007-01-17 繊維処理剤、繊維処理方法、この繊維処理剤により処理された繊維および布帛

Country Status (5)

Country Link
JP (1) JPWO2007083672A1 (zh)
KR (1) KR20080083665A (zh)
CN (1) CN101370977A (zh)
TW (1) TW200736449A (zh)
WO (1) WO2007083672A1 (zh)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110892109A (zh) * 2017-07-14 2020-03-17 信越化学工业株式会社 含功能剂纤维及其制造方法

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2317007B1 (en) * 2008-08-11 2015-09-30 Kurashiki Boseki Kabushiki Kaisha Sliver for spinning, process for producing same, and spun yarn and textile product both using same
TWI446868B (zh) * 2010-07-26 2014-08-01 Hung Jung Liu 植物栽種體製造方法
CN102352563A (zh) * 2011-07-29 2012-02-15 苏州卡奇特纺织有限公司 一种粘棉织物用抗静电剂
CN102352562A (zh) * 2011-07-29 2012-02-15 苏州卡奇特纺织有限公司 一种毛晴织物用抗静电剂
CN112220961B (zh) * 2020-09-14 2022-11-04 株洲千金药业股份有限公司 一种防褥除臭芯片与产妇垫及其制备方法
CN116005361B (zh) * 2022-12-29 2023-07-21 东莞盛翔新材料技术有限公司 一种纤维素-胶原蛋白复合纳米纤维膜的制备方法

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997040227A1 (fr) * 1996-04-19 1997-10-30 Idemitsu Petrochemical Co., Ltd. Traitement de textiles et fibres et textiles en resultant
JP2000270879A (ja) * 1999-03-26 2000-10-03 Mitsubishi Rayon Co Ltd 核酸固定化ゲル保持繊維並びに該繊維配列体及びその薄片
JP2002071693A (ja) * 2000-09-05 2002-03-12 Mitsubishi Rayon Co Ltd 核酸結合繊維の製造方法
JP2005226187A (ja) * 2004-02-12 2005-08-25 National Printing Bureau 偽造防止用紙、該用紙の製造方法及び該用紙の識別方法

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997040227A1 (fr) * 1996-04-19 1997-10-30 Idemitsu Petrochemical Co., Ltd. Traitement de textiles et fibres et textiles en resultant
JP2000270879A (ja) * 1999-03-26 2000-10-03 Mitsubishi Rayon Co Ltd 核酸固定化ゲル保持繊維並びに該繊維配列体及びその薄片
JP2002071693A (ja) * 2000-09-05 2002-03-12 Mitsubishi Rayon Co Ltd 核酸結合繊維の製造方法
JP2005226187A (ja) * 2004-02-12 2005-08-25 National Printing Bureau 偽造防止用紙、該用紙の製造方法及び該用紙の識別方法

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110892109A (zh) * 2017-07-14 2020-03-17 信越化学工业株式会社 含功能剂纤维及其制造方法

Also Published As

Publication number Publication date
CN101370977A (zh) 2009-02-18
TW200736449A (en) 2007-10-01
KR20080083665A (ko) 2008-09-18
JPWO2007083672A1 (ja) 2009-06-11

Similar Documents

Publication Publication Date Title
WO2007083672A1 (ja) 繊維処理剤、繊維処理方法、この繊維処理剤により処理された繊維および布帛
CN101591859B (zh) 一种艾叶油微胶囊织物复合整理剂及其应用
KR20060121285A (ko) 섬유 처리액, 개질 섬유 포백 및 그의 제조방법
Viswanathan et al. Chlorhexidine-calcium phosphate nanoparticles—Polymer mixer based wound healing cream and their applications
CN106366214B (zh) 壳聚糖季铵盐抗菌剂、抗菌液及其制备工艺
CN108503727A (zh) 壳聚糖季铵盐抗菌织物、卫生用品及其制备工艺
KR20070035090A (ko) 방직 섬유 및 직물에 복수회 적용 가능한 피니쉬
Michalicha et al. Poly (levodopa)-modified β-glucan as a candidate for wound dressings
EP3424487B1 (en) Networked dispersion of biocellulose microfibrils in water
EP1541748A1 (en) Fiber processing agent and fiber processed with the fiber processing agent
JP4796845B2 (ja) アミノ酸誘導体徐放性重合体、該重合体を含有する化粧料及び繊維構造物並びにそれらの製造法及び再生処理法
KR102428126B1 (ko) 천연 생물활성을 갖는 보습 엘라스토머성 유연 물품 및 제조방법
US20160106879A1 (en) Antiseptic wound dressing
JPH0375665B2 (zh)
JP4592459B2 (ja) キトサンを含む抗菌組成物
Uddin Cellulose fibers: antimicrobial finishing
KR100569227B1 (ko) 초음파를 이용한 키토산-젤라틴-알진 스폰지의 제조방법
KR102215832B1 (ko) 하이드로겔 마스크팩 및 이의 제조방법
KR101418460B1 (ko) 내구성이 우수한 피톤치드 마이크로 캡슐을 포함하는 라텍스 포움 및 이의 제조방법
Lin et al. Common, existing and future applications of antimicrobial textile materials
Liu et al. Bio-functional textiles
JP2004084154A (ja) 繊維処理剤およびこの繊維処理剤により処理された繊維
JP2004300638A (ja) 繊維処理用マイクロカプセル及びそれを付着した繊維構造物
KR100572676B1 (ko) 키토산을 함유하는 액상 원적외선 방사물질의 제조방법
KR102058695B1 (ko) 게르마늄 이온이 함유된 섬유원단으로 제작된 물품 및 게르마늄 이온이 함유된 물품

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application
ENP Entry into the national phase

Ref document number: 2007554927

Country of ref document: JP

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 200780002402.3

Country of ref document: CN

Ref document number: 1020087017321

Country of ref document: KR

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 07706920

Country of ref document: EP

Kind code of ref document: A1